Pages that link to "Q45307034"
Jump to navigation
Jump to search
The following pages link to Impaired glucose tolerance in the R6/1 transgenic mouse model of Huntington's disease. (Q45307034):
Displaying 18 items.
- Mouse models of polyglutamine diseases: review and data table. Part I (Q26853025) (← links)
- Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II. (Q27005950) (← links)
- A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in mice (Q28391627) (← links)
- Beyond the brain: widespread pathology in Huntington's disease (Q33483188) (← links)
- Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease (Q33517121) (← links)
- Functions of huntingtin in germ layer specification and organogenesis (Q34965525) (← links)
- Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models (Q37112122) (← links)
- Polyglutamine toxicity in non-neuronal cells (Q37709833) (← links)
- Role of manganese in neurodegenerative diseases (Q37941268) (← links)
- Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB. (Q38013005) (← links)
- HAP1 helps to regulate actin-based transport of insulin-containing granules in pancreatic β cells (Q38903098) (← links)
- Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A. (Q42845671) (← links)
- IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice. (Q45296557) (← links)
- Huntington's Disease and Diabetes: Chronological Sequence of its Association (Q45811505) (← links)
- Surrogate measures of insulin resistance: of rats, mice, and men. (Q46145603) (← links)
- Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders (Q46309597) (← links)
- The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease (Q90593606) (← links)
- Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention (Q92017934) (← links)